A study of crizotinib for children and young adults with cancer (CRISP)

This study is looking at crizotinib by itself and with temsirolimus.

It is open to children and young people whose cancer:

• has come back after treatment

• didn’t respond to treatment

Please note, we use the term ‘you’ in this summary, but of course if you are a parent of a child with cancer, we are referring to your child.